Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Infectious Disorders Drug Targets|April 8, 2011
Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosisEsther Vicente, Raquel Villar, Silvia Pérez-Silanes, et al.
Chemical Biology & Drug Design|May 25, 2010
Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAREsther Vicente, Pablo R Duchowicz, Erlinda del V Ortiz, et al.
Orphanet Journal of Rare Diseases|February 11, 2021
Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, SpainEsther Vicente, Ainara Ruiz de Sabando, Fermín García, et al.
Patient Preference and Adherence|March 5, 2026
A Multidimensional Framework for Pharmaceutical Care to Enhance Medication Adherence and Patient Engagement: The CMO-MAPEX ModelRamón Morillo-Verdugo, Olatz Ibarra-Barrueta, Maria Teresa Martin Conde, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 1, 2021
Clinical features and incidence trends of amyotrophic lateral sclerosis in Navarre, Spain, 2007-2018: a population-based studyIvonne Jericó, Itsaso Elizalde-Beiras, Inmaculada Pagola, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxidesEsther Vicente, Pablo R Duchowicz, Diego Benítez, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 1, 2013
Evolution of a multicomponent system: computational and mechanistic studies on the chemo- and stereoselectivity of a divergent processSalomé Llabrés, Esther Vicente-García, Sara Preciado, et al.
Molecules (Basel, Switzerland)|February 9, 2008
Substitutions of fluorine atoms and phenoxy groups in the synthesis of quinoxaline 1,4-di-N-oxide derivativesEsther Vicente, Raquel Villar, Asunción Burguete, et al.
Pageof 8